# The Role of Biomarker in Serum, Cerebrospinal Fluid and Parenchyma in the Context of Aneurysmal Subarachnoid Hemorrhage.

> **NCT02142166** · NA · UNKNOWN · sponsor: **RWTH Aachen University** · enrollment: 310 (estimated)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **PROCEDURE:** Biomarker in serum, liquor, micro-dialysate
- **PROCEDURE:** Biomarker in serum and in liquor

## Key facts

- **NCT ID:** NCT02142166
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142166, "The Role of Biomarker in Serum, Cerebrospinal Fluid and Parenchyma in the Context of Aneurysmal Subarachnoid Hemorrhage.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02142166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*